FDA expands monkeypox vaccine authorization to increase dose supply five-fold

FDA expands monkeypox vaccine authorization to increase dose supply five-fold


A health worker administers a dose of the Bavarian Nordic A/S Jynneos monkeypox vaccine at a vaccination site in West Hollywood, California, on Wednesday, Aug. 3, 2022.

Jill Connelly | Bloomberg | Getty Images

The Food and Drug Administration on Tuesday expanded its authorization for the monkeypox vaccine in a way that would significantly boost the limited supply of shots.

The FDA will allow health-care providers to administer the shots through intradermal injection, or between the layers of the skin, which will increase the supply of doses by as much as fivefold. The vaccine is traditionally administered through subcutaneous injection, which goes into the fat layer beneath the skin. The intradermal injections are only for adults.

The emergency authorization also allows people under age 18 to receive the vaccine if they are at high risk of monkeypox infection. People under age 18 would receive the shot through subcutaneous injection.

Jynneos is the only FDA approved monkeypox vaccine in the U.S. The shots are administered in two doses 28 days apart. Jynneos is manufactured by Bavarian Nordic, a biotech company based in Denmark.

The U.S. has struggled to keep with up demand for the shots as the monkeypox outbreak grows, which has made it difficult for people to get appointments and lead to long lines outside clinics.

The U.S. is fighting the largest monkeypox outbreak in the world with nearly 9,000 cases across 49 states, Washington D.C. and Puerto Rico, according to the Centers for Disease Control and Prevention.

Health and Human Services Secretary Xavier Becerra declared the outbreak a public health emergency last week. The U.S. last declared a public health emergency in response to Covid-19 in 2020.

HHS has made more than 1 million doses available to state and local health departments since May. More than 620,000 doses have been shipped to jurisdictions so far, according to HHS.

This is breaking news. Please check back for updates.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Supreme Court allows Trump’s cuts to health research grants over DEI policies
Health

Supreme Court allows Trump’s cuts to health research grants over DEI policies

The Supreme Court on Thursday allowed Trump administration broad cuts to National Institutes of Health grants as part of the federal government’s campaign against diversity, equity and inclusion policies. But in a mixed decision the court left in place a different part of the lower court judge’s ruling that threw out the administration’s guidance document that introduced the policy, […]

Read More
Microplastics are everywhere. Here’s why that matters to big oil
Health

Microplastics are everywhere. Here’s why that matters to big oil

Microplastics are increasingly being found in our bodies and food supply.  They are defined as pieces of plastic smaller than 5 millimeters — about the size of a pencil eraser. But they can also be much smaller, like the size of a virus particle or a strand of DNA. Petrochemicals, the building blocks of plastic, […]

Read More
FDA approves first-ever glucose monitoring system for weight loss from Signos 
Health

FDA approves first-ever glucose monitoring system for weight loss from Signos 

Woman with Signos wearable and app Source: Signos The Food and Drug Administration on Wednesday approved the first-ever glucose monitoring system specifically for weight loss from the startup Signos, establishing a new option for Americans to manage their weight.  Current treatment options for losing weight – popular drugs like GLP-1s and surgical interventions – are […]

Read More